Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004641 |
---|---|
Receipt number | R000005536 |
Scientific Title | Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancer |
Date of disclosure of the study information | 2010/12/01 |
Last modified on | 2015/06/01 14:06:25 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/01 00:11:15 | ||
2 | Update | 2012/03/06 20:13:33 | Recruitment status |
|
3 | Update | 2012/12/03 15:51:26 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2015/06/01 14:01:11 | TEL Last name of contact person Last name of contact person Address Address |
|
5 | Update | 2015/06/01 14:06:25 | Recruitment status |